Standards of care for anemia management in oncology: focus on lung carcinoma.
about
Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy.Pharmacokinetic and pharmacodynamic profiles of subcutaneous administration of continuous erythropoietin receptor activator in lung cancer patients with anemia induced by chemotherapy.
P2860
Standards of care for anemia management in oncology: focus on lung carcinoma.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Standards of care for anemia management in oncology: focus on lung carcinoma.
@ast
Standards of care for anemia management in oncology: focus on lung carcinoma.
@en
Standards of care for anemia management in oncology: focus on lung carcinoma.
@nl
type
label
Standards of care for anemia management in oncology: focus on lung carcinoma.
@ast
Standards of care for anemia management in oncology: focus on lung carcinoma.
@en
Standards of care for anemia management in oncology: focus on lung carcinoma.
@nl
prefLabel
Standards of care for anemia management in oncology: focus on lung carcinoma.
@ast
Standards of care for anemia management in oncology: focus on lung carcinoma.
@en
Standards of care for anemia management in oncology: focus on lung carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Standards of care for anemia management in oncology: focus on lung carcinoma.
@en
P2093
Alan Colowick
Corey J Langer
John A Glaspy
P2860
P304
P356
10.1002/CNCR.10712
P407
P577
2002-08-01T00:00:00Z